Translational Psychiatry, Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany; Center of Brain, Behavior, and Metabolism, University of Lübeck, Lübeck, Germany.
Department of Psychiatry, University of Basel, Basel, Switzerland.
Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 May;9(5):522-532. doi: 10.1016/j.bpsc.2023.07.010. Epub 2023 Jul 31.
While the exploration of serotonergic psychedelics as psychiatric medicines deepens, so does the pressure to better understand how these compounds act on the brain.
We used a double-blind, placebo-controlled, crossover design and administered lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), and d-amphetamine in 25 healthy participants. By using spectral dynamic causal modeling, we mapped substance-induced changes in effective connectivity between the thalamus and different cortex types (unimodal vs. transmodal) derived from a previous study with resting-state functional magnetic resonance imaging data. Due to the distinct pharmacological modes of action of the 3 substances, we were able to investigate specific effects mainly driven by different neurotransmitter systems on thalamocortical and corticothalamic interactions.
Compared with placebo, all 3 substances increased the effective connectivity from the thalamus to specific unimodal cortices, whereas the influence of these cortices on the thalamus was reduced. These results indicate increased bottom-up and decreased top-down information flow between the thalamus and some unimodal cortices. However, for the amphetamines, we found the opposite effects when examining the effective connectivity with transmodal cortices, including parts of the salience network. Intriguingly, LSD increased the effective connectivity from the thalamus to both unimodal and transmodal cortices, indicating a breach in the hierarchical organization of ongoing brain activity.
The results advance our knowledge about the action of psychedelics on the brain and refine current models aiming to explain the underlying neurobiological processes.
随着对血清素能致幻剂作为精神药物的探索不断深入,人们越来越需要更好地了解这些化合物在大脑中的作用方式。
我们采用双盲、安慰剂对照、交叉设计,在 25 名健康参与者中给予麦角酸二乙酰胺(LSD)、3,4-亚甲二氧基甲基苯丙胺(MDMA)和苯丙胺。通过使用谱动态因果建模,我们根据之前使用静息态功能磁共振成像数据的研究,映射了物质诱导的丘脑与不同皮层类型(单一模态与跨模态)之间有效连接的变化。由于这 3 种物质的药理学作用模式不同,我们能够研究主要由不同神经递质系统驱动的特定作用对丘脑皮质和皮质丘脑相互作用的影响。
与安慰剂相比,所有 3 种物质都增加了丘脑到特定单一模态皮质的有效连接,而这些皮质对丘脑的影响则降低了。这些结果表明,丘脑与一些单一模态皮质之间的上下信息流增加。然而,对于安非他命,当我们检查与跨模态皮质的有效连接时,我们发现了相反的效果,包括突显网络的一部分。有趣的是,LSD 增加了丘脑到单一模态和跨模态皮质的有效连接,表明大脑活动的分层组织被打破。
这些结果提高了我们对致幻剂在大脑中作用的认识,并完善了当前旨在解释潜在神经生物学过程的模型。